WallStreetZenWallStreetZen

NASDAQ: ETON
Eton Pharmaceuticals Inc Earnings & Revenue

ETON past revenue growth

How has ETON's revenue growth performed historically?
Company
35.69%
Industry
10.5%
Market
19.65%
ETON's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ETON's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ETON's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ETON earnings and revenue history

Current Revenue
$35.3M
Current Earnings
$913.0k
Current Profit Margin
2.6%

ETON Return on Equity

Current Company
5.7%
Current Industry
13.6%
Current Market
28.2%
ETON's Return on Equity (5.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ETON announces earnings.

ETON Return on Assets

Current Company
2.9%
Current Industry
3.5%
ETON is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ETON Return on Capital Employed

Current Company
3.5%
Current Industry
5.8%
ETON has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ETON vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ETON$35.30M$1.48M$913.00k+134.30%N/A
SCYX$140.39M$104.31M$101.33M+253.03%N/A
EGRX$257.55M$57.18M$11.95M+3.61%-14.47%
INCR$94.81M-$10.66M-$16.52M+148.94%N/A
RMTI$86.62M-$2.20M-$8.42M+6.24%N/A

Eton Pharmaceuticals Earnings & Revenue FAQ

What were ETON's earnings last quarter?

On Invalid Date, Eton Pharmaceuticals (NASDAQ: ETON) reported Q1 2024 earnings per share (EPS) of -$0.03, up 70% year over year. Total Eton Pharmaceuticals earnings for the quarter were -$811.00 thousand. In the same quarter last year, Eton Pharmaceuticals's earnings per share (EPS) was -$0.10.

If you're new to stock investing, here's how to buy Eton Pharmaceuticals stock.

What was ETON's earnings growth in the past year?

As of Q3 2024, Eton Pharmaceuticals's earnings has grown year over year. Eton Pharmaceuticals's earnings in the past year totalled $913.00 thousand.

What was ETON's revenue last quarter?

On Invalid Date, Eton Pharmaceuticals (NASDAQ: ETON) reported Q1 2024 revenue of $7.97 million up 50.19% year over year. In the same quarter last year, Eton Pharmaceuticals's revenue was $5.30 million.

What was ETON's revenue growth in the past year?

As of Q3 2024, Eton Pharmaceuticals's revenue has grown 35.69% year over year. This is 25.18 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.5%. Eton Pharmaceuticals's revenue in the past year totalled $35.30 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.